A detailed history of Oregon Public Employees Retirement Fund transactions in Regenxbio Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 11,045 shares of RGNX stock, worth $107,357. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,045
Previous 10,845 1.84%
Holding current value
$107,357
Previous $228,000 43.42%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$11.51 - $21.53 $2,302 - $4,306
200 Added 1.84%
11,045 $129,000
Q1 2024

May 02, 2024

SELL
$12.17 - $24.61 $12,170 - $24,610
-1,000 Reduced 8.44%
10,845 $228,000
Q4 2023

Feb 12, 2024

SELL
$12.89 - $20.82 $2,578 - $4,164
-200 Reduced 1.66%
11,845 $212,000
Q3 2023

Oct 26, 2023

BUY
$16.46 - $19.99 $4,938 - $5,996
300 Added 2.55%
12,045 $198,000
Q2 2023

Jul 26, 2023

SELL
$17.23 - $21.71 $6,892 - $8,684
-400 Reduced 3.29%
11,745 $234,000
Q1 2023

May 04, 2023

SELL
$18.08 - $24.55 $6,906 - $9,378
-382 Reduced 3.05%
12,145 $229,000
Q4 2022

Jan 26, 2023

BUY
$20.4 - $24.73 $917 - $1,112
45 Added 0.36%
12,527 $0
Q3 2022

Nov 01, 2022

BUY
$22.29 - $35.04 $780 - $1,226
35 Added 0.28%
12,482 $330,000
Q2 2022

Jul 25, 2022

SELL
$19.35 - $35.04 $30,882 - $55,923
-1,596 Reduced 11.37%
12,447 $307,000
Q1 2022

Apr 21, 2022

SELL
$24.62 - $34.31 $9,848 - $13,724
-400 Reduced 2.77%
14,043 $466,000
Q4 2021

Feb 01, 2022

BUY
$30.19 - $40.28 $14,732 - $19,656
488 Added 3.5%
14,443 $472,000
Q3 2021

Oct 19, 2021

SELL
$29.09 - $45.68 $2,909 - $4,568
-100 Reduced 0.71%
13,955 $585,000
Q1 2021

Apr 20, 2021

BUY
$33.61 - $49.95 $66,715 - $99,150
1,985 Added 16.45%
14,055 $479,000
Q4 2020

Feb 09, 2021

SELL
$26.52 - $49.35 $23,549 - $43,822
-888 Reduced 6.85%
12,070 $547,000
Q3 2020

Nov 03, 2020

BUY
$27.01 - $40.26 $8,103 - $12,078
300 Added 2.37%
12,958 $356,000
Q2 2020

Jul 21, 2020

BUY
$27.75 - $43.44 $8,325 - $13,032
300 Added 2.43%
12,658 $466,000
Q3 2019

Nov 07, 2019

BUY
$31.84 - $50.88 $6,368 - $10,176
200 Added 1.65%
12,358 $440,000
Q2 2019

Jul 16, 2019

BUY
$42.0 - $59.29 $20,916 - $29,526
498 Added 4.27%
12,158 $625,000
Q1 2019

May 07, 2019

BUY
$40.82 - $62.45 $8,613 - $13,176
211 Added 1.84%
11,660 $668,000
Q4 2018

Feb 07, 2019

SELL
$39.11 - $75.15 $18.3 Million - $35.2 Million
-468,837 Reduced 97.62%
11,449 $480,000
Q4 2018

Feb 05, 2019

BUY
$39.11 - $75.15 $18.8 Million - $36.1 Million
480,286 New
480,286 $11,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $420M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.